Erratum: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: Study protocol for a randomized controlled study (Trials (2019) 20 (725) DOI: 10.1186/s13063-019-3770-0)

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After publication of our article [1] the authors have notified us of two typos in the Trial status. Originally published phrase Recruitment started in September 2018 and is planned to end in October 2018, with 120 patients randomized. Treatment with TMP finished in October 2019. We disposal the data at present. The current protocol version is 2.0, dated 28 September 2018. Correct phrase Recruitment started in September 2018 and is planned to end in October 2019, with 120 patients randomized. Treatment with TMP will be finished in March 2020. We disposal the data at present. The current protocol version is 2.0, dated 28 September 2018.

Cite

CITATION STYLE

APA

Chen, Y., He, W., Ouyang, H., Liu, C., Hong, C., Wang, T., … Wang, J. (2020, March 30). Erratum: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: Study protocol for a randomized controlled study (Trials (2019) 20 (725) DOI: 10.1186/s13063-019-3770-0). Trials. BioMed Central Ltd. https://doi.org/10.1186/s13063-020-04245-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free